首页 > 最新文献

Medecine tropicale et sante internationale最新文献

英文 中文
[Evaluation of the management of hypertension among stroke patients in a neurology department of Côte d'Ivoire]. [科特迪瓦神经科对中风患者高血压管理的评估]。
Pub Date : 2024-01-16 eCollection Date: 2024-03-31 DOI: 10.48327/mtsi.v4i1.2024.366
Any Gnazégbo, Hiénéya Armel Karidioula, Assata Sylla, Kotchi Élysée Bony, Yannick Thibaut Koffi, Aïcha Touré, Bah Abdoul Kader Koné, Ange-Éric Kouaméassouan

Introduction: Reducing blood pressure after stroke is important to prevent recurrent stroke, but we have no data about the control of blood pressure in our context. The purpose of this study was to assess management of hypertension among post-stroke patients in a neurology department.

Method: It was a retrospective study involving hypertensive stroke patients. They were followed up at 1, 3, 6 and 12 months after discharge.

Results: 141 patients fulfilled the inclusion criteria. The mean age was 61 years. Almost all patients (94.3%) received a dual antihypertensive therapy combining mainly an ACE inhibitor and a diuretic (70.2%). During follow-up, only 76 patients were assessed at M1, 50 at M3, 44 at M6 and 42 at M12. The average monthly cost of antihypertensive treatment was 13,771 CFA francs (21 euros). Non-adherence to antihypertensive medication were mostly noted in widows, patients without occupation, those with low education and no health insurance. At one year, blood pressure was controlled in 80% of the 42 patients still present. Non-control of blood pressure was related to poor therapeutic compliance (p<0.05).

Conclusion: This study highlights follow-up issues in hypertensive post-stroke patients with a high number of lost to follow-up. Blood pressure was controlled in patients who were regularly followed and adherent to antihypertensive treatment.

介绍:脑卒中后降低血压对预防脑卒中复发非常重要,但我们没有关于我国血压控制情况的数据。本研究旨在评估神经内科脑卒中后患者的高血压管理情况:这是一项涉及高血压中风患者的回顾性研究。结果:141 名患者符合纳入标准:结果:141 名患者符合纳入标准。平均年龄为 61 岁。几乎所有患者(94.3%)都接受了双重降压治疗,主要是 ACE 抑制剂和利尿剂(70.2%)。在随访期间,只有 76 名患者在 M1、50 名在 M3、44 名在 M6 和 42 名在 M12 接受了评估。降压治疗的月平均费用为 13,771 非洲法郎(21 欧元)。不坚持服用降压药的主要是寡妇、无职业者、低学历者和无医疗保险者。一年后,42 名患者中有 80% 的血压得到了控制。血压未得到控制与治疗依从性差有关(p 结论:这项研究强调了对大量中风后高血压患者的随访问题。定期随访并坚持降压治疗的患者血压得到了控制。
{"title":"[Evaluation of the management of hypertension among stroke patients in a neurology department of Côte d'Ivoire].","authors":"Any Gnazégbo, Hiénéya Armel Karidioula, Assata Sylla, Kotchi Élysée Bony, Yannick Thibaut Koffi, Aïcha Touré, Bah Abdoul Kader Koné, Ange-Éric Kouaméassouan","doi":"10.48327/mtsi.v4i1.2024.366","DOIUrl":"10.48327/mtsi.v4i1.2024.366","url":null,"abstract":"<p><strong>Introduction: </strong>Reducing blood pressure after stroke is important to prevent recurrent stroke, but we have no data about the control of blood pressure in our context. The purpose of this study was to assess management of hypertension among post-stroke patients in a neurology department.</p><p><strong>Method: </strong>It was a retrospective study involving hypertensive stroke patients. They were followed up at 1, 3, 6 and 12 months after discharge.</p><p><strong>Results: </strong>141 patients fulfilled the inclusion criteria. The mean age was 61 years. Almost all patients (94.3%) received a dual antihypertensive therapy combining mainly an ACE inhibitor and a diuretic (70.2%). During follow-up, only 76 patients were assessed at M1, 50 at M3, 44 at M6 and 42 at M12. The average monthly cost of antihypertensive treatment was 13,771 CFA francs (21 euros). Non-adherence to antihypertensive medication were mostly noted in widows, patients without occupation, those with low education and no health insurance. At one year, blood pressure was controlled in 80% of the 42 patients still present. Non-control of blood pressure was related to poor therapeutic compliance (p<0.05).</p><p><strong>Conclusion: </strong>This study highlights follow-up issues in hypertensive post-stroke patients with a high number of lost to follow-up. Blood pressure was controlled in patients who were regularly followed and adherent to antihypertensive treatment.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141285778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Complications of female genital mutilation: epidemiology and management of cases at Ouahigouya regional teaching hospital, Burkina Faso]. [切割女性生殖器的并发症:布基纳法索瓦希古亚地区教学医院的流行病学和病例管理]。
Pub Date : 2024-01-04 eCollection Date: 2024-03-31 DOI: 10.48327/mtsi.v4i1.2024.463
Sansan Rodrigue Sib, Évelyne Komboïgo, Moussa Sanogo, Issa Ouédraogo, Alexandre Tarnagada, Souleymane Traoré, Charlemagne Marie Ragnag-Néwende Ouédraogo

Background: Female genital mutilation is still common in Burkina Faso, despite decades of struggle against its practice. The northern region of this country has one of the highest prevalence of this practice at the national level with 76% of women mutilated. The objective of our study was to describe the health complications of female genital mutilation treated in the referral hospital in this region.

Patients and methods: This was a descriptive cross-sectional study with retrospective data collection over a 13-year period, from September 15, 2009 to September 14, 2022. Patients admitted for genital or loco-regional complications related to genital mutilation were included. Mutilated parturients without infibulation, victims of vulvar tears or who had undergone episiotomy were not included.

Results: We recorded 204 patients, representing 3,1% of consultants, and an annual frequency of 15.7 cases. The ages of the victims ranged from 15 months to 31 years. The 15-20 age group was the most represented (49.3%). Victims were more likely to come from urban than rural areas. The main reasons for consultation were vulvar stricture, dyspareunia, impossibility of sexual intercourse, and dysuria. These were medium- and long-term complications of the mutilation. These complications were related to infibulation in 81.8% of cases and to type II mutilation in 18.2%. Surgery accounted for 89.9% of treatments, with drug treatments alone accounting for 10.1%. Deinfibulation was the most common surgical procedure. No clitoral reconstruction was performed. The outcome was favourable in all cases.

Conclusion: There are many local and regional complications of genital mutilation, but fortunately their treatment has a good anatomical prognosis. However, psychological complications remain to be evaluated and managed in our context. The management of these complications should be an opportunity to raise awareness among the patients' family circles to abandon the practice.

背景:在布基纳法索,切割女性生殖器官的做法仍然很普遍,尽管几十年来人们一直在反对这种做法。该国北部地区是全国该习俗发生率最高的地区之一,76%的女性生殖器被切割。我们的研究旨在描述在该地区转诊医院接受治疗的女性外阴残割患者的健康并发症:这是一项描述性横断面研究,采用回顾性数据收集方法,时间跨度为 13 年(2009 年 9 月 15 日至 2022 年 9 月 14 日)。研究对象包括因生殖器切割导致生殖器或局部区域并发症而入院的患者。未行阴部扣锁术的残割产妇、外阴撕裂症患者或接受过外阴切开术的患者不包括在内:我们共记录了 204 名患者,占咨询者的 3.1%,年发病率为 15.7 例。受害者的年龄从 15 个月到 31 岁不等。15-20岁年龄段的患者最多(占49.3%)。受害者来自城市的比例高于农村。就诊的主要原因是外阴狭窄、性交困难、无法性交和排尿困难。这些都是外阴残割的中长期并发症。81.8%的病例的并发症与阴部扣锁术有关,18.2%的病例与第二类切割术有关。手术治疗占 89.9%,单纯药物治疗占 10.1%。切除阴蒂是最常见的手术方法。没有进行阴蒂重建手术。所有病例的治疗结果均良好:结论:切割生殖器会产生许多局部和区域性并发症,但幸运的是,这些并发症的治疗在解剖学上预后良好。然而,在我国,心理并发症仍有待评估和处理。对这些并发症的处理应成为提高患者家庭放弃这种做法的意识的契机。
{"title":"[Complications of female genital mutilation: epidemiology and management of cases at Ouahigouya regional teaching hospital, Burkina Faso].","authors":"Sansan Rodrigue Sib, Évelyne Komboïgo, Moussa Sanogo, Issa Ouédraogo, Alexandre Tarnagada, Souleymane Traoré, Charlemagne Marie Ragnag-Néwende Ouédraogo","doi":"10.48327/mtsi.v4i1.2024.463","DOIUrl":"10.48327/mtsi.v4i1.2024.463","url":null,"abstract":"<p><strong>Background: </strong>Female genital mutilation is still common in Burkina Faso, despite decades of struggle against its practice. The northern region of this country has one of the highest prevalence of this practice at the national level with 76% of women mutilated. The objective of our study was to describe the health complications of female genital mutilation treated in the referral hospital in this region.</p><p><strong>Patients and methods: </strong>This was a descriptive cross-sectional study with retrospective data collection over a 13-year period, from September 15, 2009 to September 14, 2022. Patients admitted for genital or loco-regional complications related to genital mutilation were included. Mutilated parturients without infibulation, victims of vulvar tears or who had undergone episiotomy were not included.</p><p><strong>Results: </strong>We recorded 204 patients, representing 3,1% of consultants, and an annual frequency of 15.7 cases. The ages of the victims ranged from 15 months to 31 years. The 15-20 age group was the most represented (49.3%). Victims were more likely to come from urban than rural areas. The main reasons for consultation were vulvar stricture, dyspareunia, impossibility of sexual intercourse, and dysuria. These were medium- and long-term complications of the mutilation. These complications were related to infibulation in 81.8% of cases and to type II mutilation in 18.2%. Surgery accounted for 89.9% of treatments, with drug treatments alone accounting for 10.1%. Deinfibulation was the most common surgical procedure. No clitoral reconstruction was performed. The outcome was favourable in all cases.</p><p><strong>Conclusion: </strong>There are many local and regional complications of genital mutilation, but fortunately their treatment has a good anatomical prognosis. However, psychological complications remain to be evaluated and managed in our context. The management of these complications should be an opportunity to raise awareness among the patients' family circles to abandon the practice.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151906/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141285853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Conidiobolomycosis (rhinofacial entomophthoromycosis) in Gabon. About of one case]. [加蓬的锥孢霉菌病(鼻面昆虫噬菌体病)。关于一例病例]。
Pub Date : 2023-12-13 eCollection Date: 2023-12-31 DOI: 10.48327/mtsi.v3i4.2023.457
Stéphanie Ntsame Ngoua, Josaphat Iba Ba, Sophie Coniquet, Ghislaine Moussirou Soumbou, Jean Bruno Boguikouma

Background: Entomophthoromycosis constitutes a nosological group of subcutaneous mycoses including conidiobolomycosis (rhinofacial form) and basidiobomomycosis (subcutaneous form involving the trunk and the limbs). Conidiobolomycosis is characterized by a progressive nasal and facial deformity giving, in the evolved forms, a "hippopotamus snout". The literature review finds a hundred cases, with a tropism for the humid tropical regions. Methods. We report the observation of a 25-year-old patient, living in the equatorial zone, in the south of Gabon in a humid forest area, presenting a swollen aspect of the face mainly involving the eyelids, the nose and the upper lips.

Results: The diagnosis of entomophthoromycosis was compatible with the histopathological and clinical aspects. The evolution was favorable in terms of facial aesthetics under itraconazole 300 mg/day for 2 months and corticosteroid therapy (bolus of methylprednisone 240 mg/day for 3 days relayed per os at a dose of 0.5 mg/kg/day, i.e. 30 mg/day) of prednisone), maintained for 3 months. The average nasal improvement could not be completed by surgery and the patient was lost to follow-up.

Conclusion: This second observation of conidiobolomycosis in Gabon in the same province makes Ngounié a privileged ecosystem for this affection.

背景:嗜昆虫真菌病(Entomophthoromycosis)是一组皮下真菌病,包括拟核真菌病(鼻面型)和基原真菌病(累及躯干和四肢的皮下型)。球孢子菌病的特点是鼻部和面部进行性畸形,进化型患者会出现 "河马鼻"。文献综述中发现了 100 个病例,这些病例主要发生在潮湿的热带地区。方法。我们报告了对一名 25 岁患者的观察结果,该患者生活在赤道地区,位于加蓬南部的潮湿森林地区,面部浮肿,主要涉及眼睑、鼻子和上嘴唇:昆虫噬菌体病的诊断与组织病理学和临床表现相符。伊曲康唑 300 毫克/天,连续 2 个月,皮质类固醇治疗(甲基强的松 240 毫克/天,连续 3 天,每口接替 0.5 毫克/千克/天的剂量,即 30 毫克/天),维持 3 个月。手术无法使鼻腔得到平均改善,患者失去了随访机会:结论:加蓬在同一省份第二次发现了分生孢子菌病,这使得恩古尼埃省成为该病的理想发病区。
{"title":"[Conidiobolomycosis (rhinofacial entomophthoromycosis) in Gabon. About of one case].","authors":"Stéphanie Ntsame Ngoua, Josaphat Iba Ba, Sophie Coniquet, Ghislaine Moussirou Soumbou, Jean Bruno Boguikouma","doi":"10.48327/mtsi.v3i4.2023.457","DOIUrl":"10.48327/mtsi.v3i4.2023.457","url":null,"abstract":"<p><strong>Background: </strong>Entomophthoromycosis constitutes a nosological group of subcutaneous mycoses including conidiobolomycosis (rhinofacial form) and basidiobomomycosis (subcutaneous form involving the trunk and the limbs). Conidiobolomycosis is characterized by a progressive nasal and facial deformity giving, in the evolved forms, a \"hippopotamus snout\". The literature review finds a hundred cases, with a tropism for the humid tropical regions. Methods. We report the observation of a 25-year-old patient, living in the equatorial zone, in the south of Gabon in a humid forest area, presenting a swollen aspect of the face mainly involving the eyelids, the nose and the upper lips.</p><p><strong>Results: </strong>The diagnosis of entomophthoromycosis was compatible with the histopathological and clinical aspects. The evolution was favorable in terms of facial aesthetics under itraconazole 300 mg/day for 2 months and corticosteroid therapy (bolus of methylprednisone 240 mg/day for 3 days relayed per os at a dose of 0.5 mg/kg/day, i.e. 30 mg/day) of prednisone), maintained for 3 months. The average nasal improvement could not be completed by surgery and the patient was lost to follow-up.</p><p><strong>Conclusion: </strong>This second observation of conidiobolomycosis in Gabon in the same province makes Ngounié a privileged ecosystem for this affection.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879889/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139935038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Médecine Tropicale et Santé Internationale takes a stand against editorial predation]. [国际热带医学和卫生组织反对编辑掠夺]。
Pub Date : 2023-12-08 eCollection Date: 2023-12-31 DOI: 10.48327/mtsi.v3i4.2023.429
Jean-Philippe Chippaux, Jean-Paul Boutin, Michel Develoux, Alain Epelboin, Pierre Gazin, François Moutou, Jean-François Pays, Eric Pichard

Warnings against predatory journals get stronger. Designed to capture manuscripts with the promise of rapid publication, the main aim of these journals is to charge abusive publication fees. Sometimes boasting imaginary impact factors, they are not indexed and offer no guarantee of visibility, accessibility or durability of the published article. Above all, they have no concern for the rigor and scientific integrity of the work they publish.

对掠夺性期刊的警告越来越强烈。这些期刊的主要目的是以快速发表的承诺来获取稿件,收取高昂的出版费。这些期刊有时标榜虚构的影响因子,但不被收录,也不保证所发表文章的可见性、可读性或持久性。最重要的是,它们根本不关心所发表文章的严谨性和科学性。
{"title":"[<i>Médecine Tropicale et Santé Internationale</i> takes a stand against editorial predation].","authors":"Jean-Philippe Chippaux, Jean-Paul Boutin, Michel Develoux, Alain Epelboin, Pierre Gazin, François Moutou, Jean-François Pays, Eric Pichard","doi":"10.48327/mtsi.v3i4.2023.429","DOIUrl":"10.48327/mtsi.v3i4.2023.429","url":null,"abstract":"<p><p>Warnings against predatory journals get stronger. Designed to capture manuscripts with the promise of rapid publication, the main aim of these journals is to charge abusive publication fees. Sometimes boasting imaginary impact factors, they are not indexed and offer no guarantee of visibility, accessibility or durability of the published article. Above all, they have no concern for the rigor and scientific integrity of the work they publish.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879898/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139935031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The different models of scientific journals]. [科学期刊的不同模式]。
Pub Date : 2023-12-08 eCollection Date: 2023-12-31 DOI: 10.48327/mtsi.v3i4.2023.454
Jean-Philippe Chippaux

Introduction: Scientific journals are the main source of scientific data, ensuring their registration, validation, distribution and archiving. With over 2.6 million scientific articles published each year, the turnover of scientific journals exceeds $25 billion annually. Five publishers share nearly half of this lucrative market. Scientists are the key players in the process, but other stakeholders have gradually been introduced, building various business models whose similarities and differences are described here.

Concepts underlying scientific publication: Open access to scientific papers dates back to the scientific and technical revolution of the 17th century. However, its evolution has been considerably boosted by the development of the Internet and the recognition of science as "commons".Scientific integrity is under the control of research institutions to ensure the prevention of fraud and misconduct in the course of scientific production. Usually, the scientific integrity is questioned during the manuscript reviewing process which may result in identification of flaws.

Models of scientific publications: In the historical model, readers pay for access to the document. Authors are not remunerated and renounce copyright on their articles to the publisher. The limits of the historical model became clear in the 90s, facing the cost of publishing, reduction in the number of subscribers, development of the Internet and willingness to improve manuscript evaluation.With the development of the Internet and the paradigm of open access, publishers proposed a new model in the 2000s, replacing the cost of access to articles for the reader with the payment of Article Processing Charges (APCs) paid by the author or its institution ("author pays" model). In this model, the content of the article can be freely reproduced and used, provided that the original author is credited. In addition to the evaluation of the manuscript which remains a critical factor, the cost of publication appears inequitable. However, all or part of the APCs may be waived, particularly for authors from low- and middle-income countries.For the past 15 years or so, publishers, learned societies and academic or research institutions (including libraries) have been seeking to publish reliable, open access manuscripts that respect scientific integrity while being affordable for the author.Predatory journals emerged in the late 2000s, taking advantage of the success of the authorpays model to capture APCs. Lacking a proper evaluation process resulting in poor-quality publications, these journals are rejected by most scientific institutions. On the other hand, they are particularly attractive in low- and middle-income countries because of their aggressive commercial practices (insistent invitation to submit a manuscript, low rejection rate, rapid publication, reduced APC, etc.).The purpose of each journal is to

导言:科学期刊是科学数据的主要来源,确保数据的登记、验证、分发和存档。每年发表的科学文章超过 260 万篇,科学期刊的年营业额超过 250 亿美元。在这个利润丰厚的市场中,五家出版商占据了近一半的份额。科学家是这一过程的主要参与者,但也逐渐引入了其他利益相关者,建立了各种商业模式,本文将介绍这些模式的异同:科学论文的开放获取可以追溯到 17 世纪的科技革命。然而,互联网的发展和科学被视为 "公共资源 "的认识极大地推动了它的发展。科学诚信受研究机构的控制,以确保防止科学生产过程中的欺诈和不当行为。通常,在审稿过程中,科学诚信会受到质疑,这可能会导致发现缺陷:在历史模式中,读者付费获取文献。科学出版物的模式:在历史模式中,读者付费获取文件,作者不领取报酬,并向出版商放弃其文章的版权。随着互联网的发展和开放存取模式的出现,出版商在 2000 年代提出了一种新的模式,即由作者或其机构支付文章处理费(APCs)来取代读者获取文章的费用("作者付费 "模式)。在这种模式下,文章内容可以自由复制和使用,但必须注明原作者。除了稿件评价仍是关键因素外,出版费用似乎也不公平。在过去 15 年左右的时间里,出版商、学术团体和学术或研究机构(包括图书馆)一直在寻求出版可靠的、开放存取的稿件,既尊重科学诚信,又能让作者负担得起。2000 年代后期出现了掠夺性期刊,它们利用作者付费模式的成功来攫取学术成果的使用费。这些期刊缺乏适当的评估程序,导致出版物质量低劣,因此被大多数科研机构拒之门外。另一方面,由于其积极的商业行为(坚持邀请投稿、低退稿率、快速出版、降低 APC 等),这些期刊在中低收入国家尤其具有吸引力。这就需要确保期刊的知名度,而知名度是由引用次数(在线引用和社交媒体引用)而不是所发表文章的质量决定的:同行评审:这一古老的概念直到 20 世纪才被广泛使用。在历史模式中,稿件评审一般由出版期刊的学术团体成员进行。评审可以是非盲评、单盲评(评审人匿名)或双盲评(作者和评审人匿名)。一些研究表明,盲评程序不会改变评价质量。自 90 年代初以来,出现了发表后评价,其中有几种变体。其目的是缩短出版时间,更广泛地开放评价过程,以限制偏差。这种制度除了不能保证对稿件进行更好的评价外,其主要缺点是文章在整个过程中的数据收集和分析未经验证就可查阅,而这一过程可能是漫长的:文章的成本取决于收费标准,收费标准因出版条件和出版地而异。审稿人都是志愿者。另一方面,稿件管理、编辑和发行由专业人士负责,这就需要支付一定的费用。在中低资源国家,其中一些费用较低,因为在这些国家可以实现规模经济并获得更高的收益:历史模式的局限性导致了科学期刊多种商业模式的发展,这些模式在不断演变,特别是作者付费模式,这种模式承诺开放出版物,但影响了科学生产。然而,由于审稿人数量有限且选择不当,对科学成果的评价也不尽相同。
{"title":"[The different models of scientific journals].","authors":"Jean-Philippe Chippaux","doi":"10.48327/mtsi.v3i4.2023.454","DOIUrl":"10.48327/mtsi.v3i4.2023.454","url":null,"abstract":"<p><strong>Introduction: </strong>Scientific journals are the main source of scientific data, ensuring their registration, validation, distribution and archiving. With over 2.6 million scientific articles published each year, the turnover of scientific journals exceeds $25 billion annually. Five publishers share nearly half of this lucrative market. Scientists are the key players in the process, but other stakeholders have gradually been introduced, building various business models whose similarities and differences are described here.</p><p><strong>Concepts underlying scientific publication: </strong>Open access to scientific papers dates back to the scientific and technical revolution of the 17<sup>th</sup> century. However, its evolution has been considerably boosted by the development of the Internet and the recognition of science as \"commons\".Scientific integrity is under the control of research institutions to ensure the prevention of fraud and misconduct in the course of scientific production. Usually, the scientific integrity is questioned during the manuscript reviewing process which may result in identification of flaws.</p><p><strong>Models of scientific publications: </strong>In the historical model, readers pay for access to the document. Authors are not remunerated and renounce copyright on their articles to the publisher. The limits of the historical model became clear in the 90s, facing the cost of publishing, reduction in the number of subscribers, development of the Internet and willingness to improve manuscript evaluation.With the development of the Internet and the paradigm of open access, publishers proposed a new model in the 2000s, replacing the cost of access to articles for the reader with the payment of Article Processing Charges (APCs) paid by the author or its institution (\"author pays\" model). In this model, the content of the article can be freely reproduced and used, provided that the original author is credited. In addition to the evaluation of the manuscript which remains a critical factor, the cost of publication appears inequitable. However, all or part of the APCs may be waived, particularly for authors from low- and middle-income countries.For the past 15 years or so, publishers, learned societies and academic or research institutions (including libraries) have been seeking to publish reliable, open access manuscripts that respect scientific integrity while being affordable for the author.Predatory journals emerged in the late 2000s, taking advantage of the success of the authorpays model to capture APCs. Lacking a proper evaluation process resulting in poor-quality publications, these journals are rejected by most scientific institutions. On the other hand, they are particularly attractive in low- and middle-income countries because of their aggressive commercial practices (insistent invitation to submit a manuscript, low rejection rate, rapid publication, reduced APC, etc.).The purpose of each journal is to ","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879888/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139935117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Adequacy of histopathology request forms and pathological reports of breast cancer surgical specimens in Benin]. [贝宁乳腺癌手术标本组织病理学申请表和病理学报告的适当性]。
Pub Date : 2023-12-05 eCollection Date: 2023-12-31 DOI: 10.48327/mtsi.v3i4.2023.348
Freddy Houéhanou Rodrigue Gnangnon, Falilatou Seidou, Christel Marie Laleye, Fèmi Perez Odidi, Arielle Flenon Nakou, Josiane Angéline Tonato Bagnan, Justin Lewis Denakpo, Dismand Stephan Houinato, Dansou Gaspard Gbessi

Introduction: Breast cancer requires multidisciplinary management. Pathologists and physicians communicate using the histopathology request form and the pathology report. There are some minimal criteria that both should respect.

Objective: We assessed the adequacy of histopathology request forms and pathology reports in the management of female breast cancer specimens in Southern Benin.

Method: This was a cross-sectional, descriptive and analytical study, with retrospective data collection over 57 months (4 years and 9 months). The adequacy of the histopathology request forms and pathology reports was assessed on the basis of the recommendations of the Haute Autorité de Santé (HAS) of France. Data processing was done using SPSS software. We checked frequencies with the Chi2 test, with a significance level set at 5%.

Results: 31.3% of histopathology request forms complied with HAS recommendations. Pathology reports were presented in a narrative way in 92.7% of cases and 68.8% met the minimal criteria. The presence of vascular embolus, of hormone receptors and the HER2 status were all reported in only 29.2% of the reports.

Discussion: The draft of histopathology request forms and pathology reports did not comply to the required minimal criteria. This situation could mainly be explained by the inexistence of consensus between physicians and pathologists and by the lack of immunohistochemistry. Editing national referentials and using synoptic reports would give better results.

导言乳腺癌需要多学科管理。病理学家和医生通过组织病理学申请表和病理报告进行沟通。两者都应遵守一些最低标准:我们评估了组织病理学申请表和病理学报告在贝宁南部女性乳腺癌标本管理中的适当性:这是一项横断面、描述性和分析性研究,通过回顾性数据收集,历时57个月(4年零9个月)。根据法国卫生高级管理局(HAS)的建议,对组织病理学申请表和病理学报告的适当性进行了评估。数据处理采用 SPSS 软件。我们用Chi2检验法检验了频率,显著性水平设定为5%:31.3%的组织病理学申请表符合HAS的建议。92.7%的病例以叙述方式提交病理报告,68.8%的病例符合最低标准。仅有 29.2% 的报告报告了血管栓塞、激素受体和 HER2 状态:讨论:组织病理学申请表和病理报告的草稿不符合规定的最低标准。出现这种情况的主要原因是医生和病理学家之间缺乏共识,以及缺乏免疫组化。编辑国家参考资料和使用综合报告会产生更好的效果。
{"title":"[Adequacy of histopathology request forms and pathological reports of breast cancer surgical specimens in Benin].","authors":"Freddy Houéhanou Rodrigue Gnangnon, Falilatou Seidou, Christel Marie Laleye, Fèmi Perez Odidi, Arielle Flenon Nakou, Josiane Angéline Tonato Bagnan, Justin Lewis Denakpo, Dismand Stephan Houinato, Dansou Gaspard Gbessi","doi":"10.48327/mtsi.v3i4.2023.348","DOIUrl":"10.48327/mtsi.v3i4.2023.348","url":null,"abstract":"<p><strong>Introduction: </strong>Breast cancer requires multidisciplinary management. Pathologists and physicians communicate using the histopathology request form and the pathology report. There are some minimal criteria that both should respect.</p><p><strong>Objective: </strong>We assessed the adequacy of histopathology request forms and pathology reports in the management of female breast cancer specimens in Southern Benin.</p><p><strong>Method: </strong>This was a cross-sectional, descriptive and analytical study, with retrospective data collection over 57 months (4 years and 9 months). The adequacy of the histopathology request forms and pathology reports was assessed on the basis of the recommendations of the Haute Autorité de Santé (HAS) of France. Data processing was done using SPSS software. We checked frequencies with the Chi<sup>2</sup> test, with a significance level set at 5%.</p><p><strong>Results: </strong>31.3% of histopathology request forms complied with HAS recommendations. Pathology reports were presented in a narrative way in 92.7% of cases and 68.8% met the minimal criteria. The presence of vascular embolus, of hormone receptors and the HER2 status were all reported in only 29.2% of the reports.</p><p><strong>Discussion: </strong>The draft of histopathology request forms and pathology reports did not comply to the required minimal criteria. This situation could mainly be explained by the inexistence of consensus between physicians and pathologists and by the lack of immunohistochemistry. Editing national referentials and using synoptic reports would give better results.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139935035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Assessment of a therapeutic protocol for the management of snakebite envenomations in Benin]. [贝宁蛇咬伤治疗方案评估]。
Pub Date : 2023-11-29 eCollection Date: 2023-12-31 DOI: 10.48327/mtsi.v3i4.2023.451
Harold Tankpinou Zoumenou, Jean-Philippe Chippaux, Pierre Fachehoun, Giambattista Priuli, Achille Massougbodji

Introduction: Snakebite envenomation is a major public health issue in Sub-Saharan Africa (SSA). Antivenoms are the only etiological treatment. However, the dose recommended by the manufacturer (2 vials renewed every 2 hours in case of persistent bleeding) is usually not applied due to the high cost which is borne only by the patient. Based on clinical presentation, we evaluated the administration of a single vial on admission (instead of 2 vials), which corresponds to the therapeutic protocol used in current practice in most health centers in Benin and beyond in SSA. Renewal of antivenom followed manufacturer's recommendation.

Material and method: The study took place in a first referral hospital in Tanguiéta, North Benin. All envenomed patients received a slow intravenous vial of Inoserp® Pan-Africa (IPA) upon arrival. A clinical assessment identical to that of inclusion was carried out 2, 4, 6, 12 and 24 hours later to assess the tolerance and efficacy of the IPA, as well as the need to readminister the antivenom. The occurrence, persistence or worsening of clinical hemorrhages or neurological disorders, the latter reflecting envenomation by elapids, systematically led to the injection of 2 or 4 vials of IPA, respectively. Signs of intolerance were sought before and after each administration of antivenom, then 2 weeks to 1 month after treatment, in order to estimate the incidence of adverse effects attributable to the antivenom. Efficacy of IPA was assessed by cessation of bleeding and/or normalization of whole blood coagulation test (WBCT) within 24 hours of initial administration.

Results: The study took place from July 31 to October 31, 2019. We received 53 cases of snakebites of which 43 were included. The median age was 21 [IQR: 18-31] years and the sex ratio (M/F) was 1.5. Farmers were the majority (48%). The median time to admission was 1 [IQR: 0-2] day. On admission, 32 patients (74%) presented hemostasis disorders marked by bleeding and/or abnormal WBCT. None of the patients showed neurological symptoms. The median time to normalization of WBCT was 24 [IQR: 4-72] hours. The median time to stop bleeding was 6 [IQR: 4-12] hours. In 3 of the 11 patients whose bleeding had stopped at H2, a recurrence occurred within the following 24 hours. In addition, 3 patients presented with late bleeding 24 hours after admission. Two patients (5%) died as a result of envenomation.

Discussion/conclusion: The simplified protocol represents a significant saving in the number of vials used, i.e. 1.8±0.4 vials per patient instead of the 2.4±0.2 which would have been necessary in these same patients treated according to the standard protocol (p = 2.6·10-4). However, in comparison with the results obtained during the previous clinical study, the cessation of bleeding is delayed, as is the normalization of the WBCT at the different follow-up times. I

导言:蛇咬伤是撒哈拉以南非洲(SSA)的一个主要公共卫生问题。抗蛇毒血清是唯一的病因治疗方法。然而,生产商推荐的剂量(在持续出血的情况下每 2 小时更换 2 瓶)通常无法使用,因为费用高昂,而且只能由患者承担。根据临床表现,我们评估了入院时使用单瓶抗血清(而不是 2 瓶)的情况,这符合贝宁及其他撒哈拉以南非洲国家大多数医疗中心目前使用的治疗方案。抗蛇毒血清的续用遵循制造商的建议:研究在贝宁北部坦吉耶塔的一家第一转诊医院进行。所有被蛇咬伤的患者在到达医院时都接受了一小瓶缓慢静脉注射的 Inoserp® Pan-Africa (IPA)。2 小时、4 小时、6 小时、12 小时和 24 小时后,对患者进行与入院时相同的临床评估,以评估其对 Inoserp® Pan-Africa (IPA) 的耐受性和疗效,以及是否需要重新注射抗蛇毒血清。如果出现、持续或恶化临床出血或神经失调(后者反映的是伶鼬的毒液),则系统性地分别注射 2 瓶或 4 瓶 IPA。在每次注射抗蛇毒血清之前和之后,以及治疗后 2 周至 1 个月,都会寻找不耐受的迹象,以估计抗蛇毒血清引起的不良反应的发生率。IPA的疗效以首次给药后24小时内出血停止和/或全血凝固试验(WBCT)正常来评估:研究时间为 2019 年 7 月 31 日至 10 月 31 日。我们共收到 53 例蛇咬伤病例,其中 43 例被纳入研究。年龄中位数为 21 [IQR:18-31]岁,性别比例(男/女)为 1.5。农民占大多数(48%)。入院时间中位数为 1 [IQR: 0-2] 天。入院时,32 名患者(74%)出现以出血和/或 WBCT 异常为特征的止血障碍。没有患者出现神经系统症状。WBCT恢复正常的中位时间为24[IQR:4-72]小时。止血的中位时间为 6 [IQR: 4-12] 小时。在 H2 时止血的 11 位患者中,有 3 位在随后的 24 小时内复发。此外,3 名患者在入院 24 小时后出现晚期出血。两名患者(5%)因中毒死亡:简化方案大大节省了药瓶的使用量,即每名患者只需使用 1.8±0.4 瓶,而按照标准方案治疗相同患者则需使用 2.4±0.2 瓶(p = 2.6-10-4)。不过,与之前临床研究的结果相比,出血停止的时间推迟了,不同随访时间的白细胞压积恢复正常的时间也推迟了。此外,H2 后再次注射抗蛇毒血清的次数在轻型方案中也高于标准方案,分别为 43 名接受治疗的患者中有 13 名再次注射抗蛇毒血清,而在 59 名患者中有 4 名再次注射抗蛇毒血清(P = 0.006)。与之前的研究相比,本研究中早期抗蛇毒血清不耐受症状的发生率没有明显差异(分别为 16% 和 11%;p = 0.79)。这种延迟可能会使多达三分之一的患者面临并发症风险。尽管抗蛇毒血清疗法很有效,而且还能节省抗蛇毒血清,但推荐使用这种疗法似乎并不合理。
{"title":"[Assessment of a therapeutic protocol for the management of snakebite envenomations in Benin].","authors":"Harold Tankpinou Zoumenou, Jean-Philippe Chippaux, Pierre Fachehoun, Giambattista Priuli, Achille Massougbodji","doi":"10.48327/mtsi.v3i4.2023.451","DOIUrl":"10.48327/mtsi.v3i4.2023.451","url":null,"abstract":"<p><strong>Introduction: </strong>Snakebite envenomation is a major public health issue in Sub-Saharan Africa (SSA). Antivenoms are the only etiological treatment. However, the dose recommended by the manufacturer (2 vials renewed every 2 hours in case of persistent bleeding) is usually not applied due to the high cost which is borne only by the patient. Based on clinical presentation, we evaluated the administration of a single vial on admission (instead of 2 vials), which corresponds to the therapeutic protocol used in current practice in most health centers in Benin and beyond in SSA. Renewal of antivenom followed manufacturer's recommendation.</p><p><strong>Material and method: </strong>The study took place in a first referral hospital in Tanguiéta, North Benin. All envenomed patients received a slow intravenous vial of Inoserp<sup>®</sup> Pan-Africa (IPA) upon arrival. A clinical assessment identical to that of inclusion was carried out 2, 4, 6, 12 and 24 hours later to assess the tolerance and efficacy of the IPA, as well as the need to readminister the antivenom. The occurrence, persistence or worsening of clinical hemorrhages or neurological disorders, the latter reflecting envenomation by elapids, systematically led to the injection of 2 or 4 vials of IPA, respectively. Signs of intolerance were sought before and after each administration of antivenom, then 2 weeks to 1 month after treatment, in order to estimate the incidence of adverse effects attributable to the antivenom. Efficacy of IPA was assessed by cessation of bleeding and/or normalization of whole blood coagulation test (WBCT) within 24 hours of initial administration.</p><p><strong>Results: </strong>The study took place from July 31 to October 31, 2019. We received 53 cases of snakebites of which 43 were included. The median age was 21 [IQR: 18-31] years and the sex ratio (M/F) was 1.5. Farmers were the majority (48%). The median time to admission was 1 [IQR: 0-2] day. On admission, 32 patients (74%) presented hemostasis disorders marked by bleeding and/or abnormal WBCT. None of the patients showed neurological symptoms. The median time to normalization of WBCT was 24 [IQR: 4-72] hours. The median time to stop bleeding was 6 [IQR: 4-12] hours. In 3 of the 11 patients whose bleeding had stopped at H2, a recurrence occurred within the following 24 hours. In addition, 3 patients presented with late bleeding 24 hours after admission. Two patients (5%) died as a result of envenomation.</p><p><strong>Discussion/conclusion: </strong>The simplified protocol represents a significant saving in the number of vials used, i.e. 1.8±0.4 vials per patient instead of the 2.4±0.2 which would have been necessary in these same patients treated according to the standard protocol (p = 2.6·10<sup>-4</sup>). However, in comparison with the results obtained during the previous clinical study, the cessation of bleeding is delayed, as is the normalization of the WBCT at the different follow-up times. I","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139935036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pertussis worldwide. Vaccinating children and adults]. [全球百日咳:为儿童和成人接种疫苗]。
Pub Date : 2023-11-22 eCollection Date: 2023-12-31 DOI: 10.48327/mtsi.v3i4.2023.446
Dominique Gendrel, Josette Raymond

Pertussis (whooping cough) is an important cause of morbidity and mortality in infants world-wide, and continues to be a public health concern despite high vaccination coverage. The disease, caused by bacterium Bordetella pertussis, is present in all countries. Before vaccines became widely available in the 1950s, pertussis was one of the most common childhood diseases worldwide. According to WHO, estimation of deaths was 4 millions/year in 1950 and 100 000/year in 2015. But morbidity remains important with a high circulation of the bacterium determining atypical clinical forms after whole cell or acellular vaccines use. This is due mainly to the absence of booster doses in adolescents and adults. Major progress are generalisation of PCR and vaccination of mother during pregnancy. A resurgence of pertussis is observed after generalisation of acellular vaccines use. In China the progression of allele ptxPl was found in all areas following the use of acellular vaccine. This allele, rare before acellullar vaccine, is linked to a macrolide resistance, and reaches more than 30% of strains isolated in hospitalised children.These evolutions must be evaluated in clinical forms and genotyping of all strains, in all areas.

百日咳(百日咳)是全世界婴儿发病和死亡的重要原因,尽管疫苗接种率很高,但它仍然是一个公共卫生问题。这种由百日咳杆菌引起的疾病在所有国家都存在。在 20 世纪 50 年代疫苗普及之前,百日咳是全球最常见的儿童疾病之一。据世界卫生组织估计,1950 年的死亡人数为每年 400 万,2015 年为每年 10 万。但是,在使用全细胞或无细胞疫苗后,由于细菌的高流通性决定了非典型临床形式,因此发病率仍然很高。这主要是由于青少年和成年人没有接种加强剂所致。目前的主要进展是 PCR 的普及和母亲在怀孕期间接种疫苗。在普遍使用无细胞疫苗后,百日咳再次流行。在中国,使用无细胞疫苗后,所有地区都发现了等位基因ptxPl的增长。在接种无细胞疫苗之前,这种等位基因非常罕见,它与大环内酯类药物耐药性有关,在住院儿童中分离出的菌株中,这种等位基因占 30% 以上。
{"title":"[Pertussis worldwide. Vaccinating children and adults].","authors":"Dominique Gendrel, Josette Raymond","doi":"10.48327/mtsi.v3i4.2023.446","DOIUrl":"10.48327/mtsi.v3i4.2023.446","url":null,"abstract":"<p><p>Pertussis (whooping cough) is an important cause of morbidity and mortality in infants world-wide, and continues to be a public health concern despite high vaccination coverage. The disease, caused by bacterium <i>Bordetella pertussis,</i> is present in all countries. Before vaccines became widely available in the 1950s, pertussis was one of the most common childhood diseases worldwide. According to WHO, estimation of deaths was 4 millions/year in 1950 and 100 000/year in 2015. But morbidity remains important with a high circulation of the bacterium determining atypical clinical forms after whole cell or acellular vaccines use. This is due mainly to the absence of booster doses in adolescents and adults. Major progress are generalisation of PCR and vaccination of mother during pregnancy. A resurgence of pertussis is observed after generalisation of acellular vaccines use. In China the progression of allele <i>ptxPl</i> was found in all areas following the use of acellular vaccine. This allele, rare before acellullar vaccine, is linked to a macrolide resistance, and reaches more than 30% of strains isolated in hospitalised children.These evolutions must be evaluated in clinical forms and genotyping of all strains, in all areas.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139935116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ear tuberculosis concomitant with pulmonary localization in an HIV-immunosuppressed patient, in Bamako, Mali]. [马里巴马科一名艾滋病毒免疫抑制患者并发肺结核]。
Pub Date : 2023-11-17 eCollection Date: 2023-12-31 DOI: 10.48327/mtsi.v3i4.2023.415
Farimadiané Coulibaly, Yacouba Cissoko, Aden Ibrahim Bouh, Djokdelna Ezéchiel Gandaye, Mariam Soumaré, Issa Konaté, Sounkalo Dao

Introduction/rationale: Tuberculosis remains a major public health issue. It is an opportunistic pathology, very common in HIV-immunocompromised persons, classifying it at the WHO stage 4. Ear tuberculosis remains a rare and under-diagnosed clinical form. We report here a case of ear tuberculosis concomitant with pulmonary localization in an HIV-immunosuppressed person on triple antiretroviral therapy aged 32 years hospitalized in Bamako (Mali) to discuss the diagnostic and therapeutic difficulties posed by this rare localization.

Description of the case: The patient had a chronic productive cough, otalgia and right chronic purulent otorrhea. The search for acid-resistant bacilli was positive for direct examination in gastric casing fluid and swabbing of the ear pus, confirming the diagnosis of tuberculosis. Anti-tuberculosis treatment instituted for 6 months associated with adjuvants resulted in complete healing of the patient.

Discussion/conclusion: Although rare, ear localization must be actively sought. Etiological treatment must be instituted upon confirmation of the diagnosis to avoid complications and sequelae.

导言/理由:结核病仍然是一个重大的公共卫生问题。它是一种机会性病变,在艾滋病毒免疫力低下的人群中非常常见,属于世界卫生组织的第 4 阶段。耳结核仍然是一种罕见且诊断不足的临床形式。我们在此报告一例在巴马科(马里)住院的 32 岁接受三联抗逆转录病毒疗法的 HIV 免疫抑制患者的耳结核合并肺结核病例,以探讨这种罕见的局部病变所带来的诊断和治疗困难:患者患有慢性有痰咳嗽、耳痛和右侧慢性化脓性耳泻。在胃套管液和耳脓拭子中寻找耐酸杆菌,结果均呈阳性,确诊为肺结核。经过 6 个月的抗结核治疗和辅助治疗,患者完全康复:讨论/结论:耳部结核病虽然罕见,但必须积极寻找病因。讨论/结论:耳部定位虽然罕见,但必须积极就诊,确诊后必须进行病因治疗,以避免并发症和后遗症。
{"title":"[Ear tuberculosis concomitant with pulmonary localization in an HIV-immunosuppressed patient, in Bamako, Mali].","authors":"Farimadiané Coulibaly, Yacouba Cissoko, Aden Ibrahim Bouh, Djokdelna Ezéchiel Gandaye, Mariam Soumaré, Issa Konaté, Sounkalo Dao","doi":"10.48327/mtsi.v3i4.2023.415","DOIUrl":"10.48327/mtsi.v3i4.2023.415","url":null,"abstract":"<p><strong>Introduction/rationale: </strong>Tuberculosis remains a major public health issue. It is an opportunistic pathology, very common in HIV-immunocompromised persons, classifying it at the WHO stage 4. Ear tuberculosis remains a rare and under-diagnosed clinical form. We report here a case of ear tuberculosis concomitant with pulmonary localization in an HIV-immunosuppressed person on triple antiretroviral therapy aged 32 years hospitalized in Bamako (Mali) to discuss the diagnostic and therapeutic difficulties posed by this rare localization.</p><p><strong>Description of the case: </strong>The patient had a chronic productive cough, otalgia and right chronic purulent otorrhea. The search for acid-resistant bacilli was positive for direct examination in gastric casing fluid and swabbing of the ear pus, confirming the diagnosis of tuberculosis. Anti-tuberculosis treatment instituted for 6 months associated with adjuvants resulted in complete healing of the patient.</p><p><strong>Discussion/conclusion: </strong>Although rare, ear localization must be actively sought. Etiological treatment must be instituted upon confirmation of the diagnosis to avoid complications and sequelae.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139935133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Failure of poliomyelitis eradication campaign with oral vaccine: there's no vaccination without adherence]. [使用口服疫苗根除脊髓灰质炎运动的失败:没有坚持就没有疫苗接种]。
Pub Date : 2023-11-16 eCollection Date: 2023-12-31 DOI: 10.48327/mtsi.v3i4.2023.402
Bernard Seytre

Thirty-five years after its launch, the Global Polio Eradication Initiative has yet to reach its original goal of 2000. Not only is the wild type 1 polio virus still endemic in two countries, but a new outbreak due to viruses derived from the live attenuated virus used for the oral vaccine has been spreading since 2016. The National Immunization Days (NID), during which teams go door-to-door and attract children to be vaccinated, have provoked violent opposition particularly in Northern Nigeria and in the area of India, Pakistan, Afghanistan. In both regions, the same rumor has developed that the vaccine contains sterilizing products, in order to limit the Muslim population. The organizers of the campaign multiplied in vain the NIDs to overcome the resistance, but pockets of insufficiently vaccinated population have persisted. This has allowed the wild virus to remain endemic and the new outbreak of vaccine-derived viruses to progress. We can wonder what the campaign would have become if its organizers had taken the time to reflect and reorient their strategy to rely on the routine vaccination of the Expanded Program on Immunization that does not arouse such opposition.

全球根除脊髓灰质炎倡议发起 35 年后,仍未实现 2000 年的最初目标。不仅野生 1 型脊髓灰质炎病毒仍在两个国家流行,而且自 2016 年以来,由用于口服疫苗的减毒活疫苗衍生病毒引起的新疫情也在蔓延。在 "全国免疫日"(NID)期间,免疫接种小组挨家挨户吸引儿童接种疫苗,但却引发了暴力反对,尤其是在尼日利亚北部以及印度、巴基斯坦和阿富汗地区。在这两个地区,都出现了同样的谣言,说疫苗含有绝育产品,目的是限制穆斯林人口。运动的组织者徒劳地增加了 NIDs 以克服阻力,但接种不足的小块人口仍然存在。这使得野病毒继续流行,而疫苗衍生病毒的新爆发则不断进展。我们不禁要问,如果这场运动的组织者能够花时间进行反思,并重新调整战略,依靠扩大免疫计划的常规疫苗接种,而不会引起如此强烈的反对,那么这场运动会变成什么样呢?
{"title":"[Failure of poliomyelitis eradication campaign with oral vaccine: there's no vaccination without adherence].","authors":"Bernard Seytre","doi":"10.48327/mtsi.v3i4.2023.402","DOIUrl":"10.48327/mtsi.v3i4.2023.402","url":null,"abstract":"<p><p>Thirty-five years after its launch, the Global Polio Eradication Initiative has yet to reach its original goal of 2000. Not only is the wild type 1 polio virus still endemic in two countries, but a new outbreak due to viruses derived from the live attenuated virus used for the oral vaccine has been spreading since 2016. The National Immunization Days (NID), during which teams go door-to-door and attract children to be vaccinated, have provoked violent opposition particularly in Northern Nigeria and in the area of India, Pakistan, Afghanistan. In both regions, the same rumor has developed that the vaccine contains sterilizing products, in order to limit the Muslim population. The organizers of the campaign multiplied in vain the NIDs to overcome the resistance, but pockets of insufficiently vaccinated population have persisted. This has allowed the wild virus to remain endemic and the new outbreak of vaccine-derived viruses to progress. We can wonder what the campaign would have become if its organizers had taken the time to reflect and reorient their strategy to rely on the routine vaccination of the Expanded Program on Immunization that does not arouse such opposition.</p>","PeriodicalId":101416,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139935134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medecine tropicale et sante internationale
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1